Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 06, 2015 07:30 ET | Source: Soricimed Biopharma Inc.

L'agent de ciblage TRPV6 combiné au nouveau SOC-C13 de Soricimed inhibe la croissance de tumeurs de cancer du sein et des ovaires

BOSTON, MASSACHUSETTS--(Marketwired - 6 mai 2015) - Soricimed Biopharma Inc., une société privée d'essais en phase clinique mettant au point des programmes de...
May 06, 2015 07:30 ET | Source: Soricimed Biopharma Inc.

Targeting TRPV6 With Soricimed's Novel SOR-C13 Inhibits Tumour Growth in Breast and Ovarian Cancer Models

BOSTON, MASSACHUSETTS--(Marketwired - May 6, 2015) - Soricimed Biopharma Inc., a private clinical stage company developing novel cancer therapeutics and diagnostics, is presenting a poster...
May 06, 2015 07:30 ET | Source: Soricimed Biopharma Inc.

Les découvertes de Soricimed appuient l'utilisation du TRPV6 comme biomarqueur pour des thérapies et des diagnostics liés au cancer des ovaires

BOSTON, MASSACHUSETTS--(Marketwired - 6 mai 2015) - Soricimed Biopharma Inc. (SBI), une société privée d'essais en phase clinique mettant au point des programmes de...
May 06, 2015 07:30 ET | Source: Soricimed Biopharma Inc.

Soricimed's Findings Support TRPV6 as a Novel and Significant Biomarker for Ovarian Cancer-Targeted Therapies and Diagnostics

BOSTON, MASSACHUSETTS--(Marketwired - May 6, 2015) - Soricimed Biopharma Inc. (SBI), a private clinical stage company developing novel cancer therapeutics and diagnostics, is presenting a...
March 18, 2014 07:30 ET | Source: Soricimed Biopharma inc.

Soricimed Biopharma nomme une nouvelle vice-présidente à la recherche et au développement

TORONTO, ONTARIO--(Marketwired - 18 mars 2014) - Soricimed Biopharma inc., une société privée d'essais en phase clinique mettant au point des thérapies et des outils...
March 18, 2014 07:30 ET | Source: Soricimed Biopharma Inc.

Soricimed Biopharma Announces New VP of R&D

TORONTO, ONTARIO--(Marketwired - March 18, 2014) - Soricimed Biopharma Inc., a private clinical stage company developing novel cancer therapeutics and diagnostics, is pleased to announce...
October 15, 2013 21:03 ET | Source: Soricimed Biopharma Inc.

Percée prometteuse de Soricimed pour le traitement du cancer du sein et de l'ovaire

SAN FRANCISCO, CALIFORNIE--(Marketwired - 15 oct. 2013) - Soricimed Biopharma Inc., une entreprise privée consacrée à la mise au point de médicaments...
October 15, 2013 21:00 ET | Source: Soricimed Biopharma Inc.

Soricimed Shows Promise in Treating Breast and Ovarian Cancer

SAN FRANCISCO, CALIFORNIA--(Marketwired - Oct. 15, 2013) - Soricimed Biopharma Inc., a private clinical stage company developing novel cancer therapeutics and diagnostics, today announced...
September 10, 2013 07:30 ET | Source: Soricimed Biopharma Inc.

Soricimed Biopharma Inc. élargit l'utilisation de la plateforme soricidine

TORONTO, ONTARIO--(Marketwired - 10 sept. 2013) - Soricimed Biopharma Inc., société privée spécialisée dans le développement de thérapies et d'outils...
September 10, 2013 07:30 ET | Source: Soricimed Biopharma Inc.

Soricimed Biopharma Inc. Extends The Soricidin Platform Technology

TORONTO, ONTARIO--(Marketwired - Sept. 10, 2013) - Soricimed Biopharma Inc., a private clinical stage company developing novel cancer therapeutics and diagnostics, is pleased to announce...